Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients-Reference-Cited by-同舟云学术

Neurocognition and Duration of Psychosis: A 10-year Follow-up of First-Episode Patients

Published:2015-06-21 Issue: Volume: Page:sbv083
ISSN:0586-7614
Container-title:Schizophrenia Bulletin
language:en
Short-container-title:SCHBUL

Author:

Rund Bjørn Rishovd,Barder Helene Eidsmo,Evensen Julie,Haahr Ulrik,Hegelstad Wenche ten Velden,Joa Inge,Johannessen Jan Olav,Langeveld Johannes,Larsen Tor Ketil,Melle Ingrid,Opjordsmoen Stein,Røssberg Jan Ivar,Simonsen Erik,Sundet Kjetil,Vaglum Per,McGlashan Thomas,Friis Svein

Publisher

Oxford University Press (OUP)

Subject

Psychiatry and Mental health

Link

http://academic.oup.com/schizophreniabulletin/article-pdf/42/1/87/7681552/sbv083.pdf

Reference78 articles.

1. Schizophrenia Is a Cognitive Illness

2. The global cognitive impairment in schizophrenia: Consistent over decades and around the world

3. Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: A 30-Year Study

4. Neuropsychological Profile in Early-Onset Schizophrenia-Spectrum Disorders: Measured With the MATRICS Battery

5. Neurocognition in first-episode schizophrenia: A meta-analytic review.

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of cognitive performance in first-episode drug-naïve schizophrenia, bipolar II disorder, and major depressive disorder patients after treatment;BMC Psychiatry;2024-06-11

2. A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort;Schizophrenia Research;2024-04

3. 20-year neurocognitive development following a schizophrenia spectrum disorder and associations with symptom severity and functional outcomes;Psychological Medicine;2024-02-12

4. First Episode of Psychosis;Advances in Medical Technologies and Clinical Practice;2024-01-19

5. The polygenic basis of relapse after a first episode of schizophrenia;European Neuropsychopharmacology;2023-10